Cite
HARVARD Citation
Cruz, F. et al. (2023). Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison. Journal of medical economics. pp. 200-207. [Online].